(1-Isopropyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)boronic acid, 95.0%, 250mg

(S)-1-(3,5-Difluorophenyl)ethanamine hydrochloride, 95.0%, 100mg

Methyl (S)-indoline-2-carboxylate, 98%, 5g

Ethyl 2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate, 95.0%, 5g

2-Methoxy-6-methylaniline, 98.0%, 25g

Sample tray ROTILABO®, 2000 ml, Height, 55 mm, 1 Piece

methyl (5S,8S,10aR)-5-(tert-butoxycarbonylamino)-6-oxo-2,3,4,5,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a][1,5]diazocine-8-carboxylate, 97, 250mg

3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile, 95%, 10mg

Long working distance plan phase 40x/0.65 IOS objective, working distance 2.74 mm

1-Amino-2-methylnaphthalene>98.0%(GC)(T)5g

N-(4-chlorophenyl)benzenesulfonamide, 95+%, 1g

2',3'-Dihydrospiro[cyclopropane-1,1'-indene]-2-carboxylic acid, 98%, 100mg

4-(Hydroxymethyl)cyclohexanone, 97.0%, 10g